Biological function of UCA1 in hepatocellular carcinoma and its clinical significance: Investigation with in vitro and meta-analysis.

Urothelial cancer associated 1 (UCA1) was upregulated in hepatocellular carcinoma (HCC) tissues and cell lines, and the expression of UCA1 was associated with several clinical features and malignant behaviours in HCC. However, none of these findings completely interpreted the role of UCA1 in HCC. We conducted this investigation to validate the expression of UCA1 and its relationship with Tumor Node Metastasis (TNM) stage in 41 HCC tissues and their paired noncancerous adjacent tissues by real-time qPCR. Furthermore, we also explored the biological functions of UCA1 in vitro with HCC cell lines. Most importantly, we conducted a comprehensive meta-analysis and bioinformatics investigation based on peer-reviewed literature and in silico approaches to further summarise the clinical value and functions of UCA1 in HCC. UCA1 expression was remarkably upregulated in HCC tissues, and its expression was profoundly higher in advanced stages than in early stages. Reducing the expression levels of UCA1 suppressed the proliferation and induced apoptosis of HCC cells. Furthermore, the present meta-analysis validated that up-regulated UCA1 was closely related to larger tumour size and advanced TNM stages, and the overexpression of UCA1 was significantly correlated with a shorter OS. Additionally, according to GO analysis, the target genes were found concentrated in the following biological processes: extracellular matrix organisation, cilium assembly and cilium morphogenesis. KEGG pathway analysis showed that the UCA1-related genes were significantly enriched in the following pathways: hippo signalling pathway, bile secretion and gastric acid secretion. This evidence hinted that UCA1 could play an indispensable proliferation-related key role in HCC via the hippo signalling pathway. However, the exact molecular mechanism needs to be verified with future functional experiments.

[1]  W. Qiang,et al.  Silencing of Urothelial Carcinoma Associated 1 Inhibits the Proliferation and Migration of Medulloblastoma Cells , 2017, Medical science monitor : international medical journal of experimental and clinical research.

[2]  J. Emond,et al.  Pretreatment neutrophil–lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma , 2018, Journal of hepatocellular carcinoma.

[3]  C. Sirlin,et al.  Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis , 2017, Abdominal Radiology.

[4]  Hirokazu Takahashi,et al.  Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods , 2017, Journal of Gastroenterology.

[5]  Zhihong Li,et al.  Application of Long Noncoding RNAs in Osteosarcoma: Biomarkers and Therapeutic Targets , 2017, Cellular Physiology and Biochemistry.

[6]  Jixiang Wu,et al.  Clinicopathological and prognostic significance of OCT4 in patients with hepatocellular carcinoma: a meta-analysis , 2017, OncoTargets and therapy.

[7]  Hong Yang,et al.  Relationship between TRAF6 and deterioration of HCC: an immunohistochemical and in vitro study , 2016, Cancer Cell International.

[8]  Gang Chen,et al.  The clinical value of miR‐193a‐3p in non‐small cell lung cancer and its potential molecular mechanism explored in silico using RNA‐sequencing and microarray data , 2018, FEBS open bio.

[9]  Gang Chen,et al.  Down-regulation of miR-26a-5p in hepatocellular carcinoma: A qRT-PCR and bioinformatics study. , 2017, Pathology, research and practice.

[10]  P. Burra,et al.  Liver Transplantation for Alcoholic Liver Disease and Hepatocellular Carcinoma , 2018, Cancers.

[11]  Huan Pang,et al.  LncRNA UCA1 Promotes Mitochondrial Function of Bladder Cancer via the MiR-195/ARL2 Signaling Pathway , 2017, Cellular Physiology and Biochemistry.

[12]  Zhen-bo Feng,et al.  The essential role of MTDH in the progression of HCC: a study with immunohistochemistry, TCGA, meta-analysis and in vitro investigation. , 2017, American journal of translational research.

[13]  Long-Bang Chen,et al.  The Emerging Roles of Long Noncoding RNA ROR (lincRNA-ROR) and its Possible Mechanisms in Human Cancers , 2016, Cellular Physiology and Biochemistry.

[14]  D. Samuel,et al.  The impact of treatment of hepatitis C with DAAs on the occurrence of HCC , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[15]  Yu-qin Pan,et al.  Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway , 2015, Oncotarget.

[16]  Wei Li,et al.  Liver transplantation vs liver resection in patients with HBV‐related hepatocellular carcinoma beyond Milan criterion: A meta‐analysis , 2018, Clinical transplantation.

[17]  Yi-huan Luo,et al.  High expression of long non‑coding HOTAIR correlated with hepatocarcinogenesis and metastasis. , 2017, Molecular medicine reports.

[18]  Xi-Zhong Shen,et al.  The Hippo pathway in hepatocellular carcinoma: Non-coding RNAs in action. , 2017, Cancer letters.

[19]  D. Dalela,et al.  Appraisal of diagnostic ability of UCA1 as a biomarker of carcinoma of the urinary bladder , 2014, Tumor Biology.

[20]  Xin Tang,et al.  Long non-coding RNA UCA1 enhances tamoxifen resistance in breast cancer cells through a miR-18a-HIF1α feedback regulatory loop , 2016, Tumor Biology.

[21]  Jin-hua Jiang,et al.  Long non-coding RNA UCA1 regulates the expression of Snail2 by miR-203 to promote hepatocellular carcinoma progression , 2017, Journal of Cancer Research and Clinical Oncology.

[22]  R. Santella,et al.  Exploration of Deregulated Long Non-Coding RNAs in Association with Hepatocarcinogenesis and Survival , 2015, Cancers.

[23]  Yang Xiao,et al.  HIF-1α-induced upregulation of lncRNA UCA1 promotes cell growth in osteosarcoma by inactivating the PTEN/AKT signaling pathway , 2018, Oncology reports.

[24]  Gang Chen,et al.  Clinical implication of long non-coding RNA NEAT1 expression in hepatocellular carcinoma patients. , 2015, International journal of clinical and experimental pathology.

[25]  Sen Lu,et al.  HBx-upregulated lncRNA UCA1 promotes cell growth and tumorigenesis by recruiting EZH2 and repressing p27Kip1/CDK2 signaling , 2016, Scientific Reports.

[26]  Guohui Li,et al.  Long non‐coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma , 2017, Life sciences.

[27]  Bing Li,et al.  LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p. , 2016, Cancer letters.

[28]  Gang Chen,et al.  The suppressive role of miR-542-5p in NSCLC: the evidence from clinical data and in vivo validation using a chick chorioallantoic membrane model , 2017, BMC Cancer.

[29]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[30]  Yuemei Hu,et al.  Clinical significance of urothelial carcinoma associated 1 in colon cancer. , 2015, International journal of clinical and experimental medicine.

[31]  Hong Yang,et al.  Diagnostic value of strand‐specific miRNA‐101‐3p and miRNA‐101‐5p for hepatocellular carcinoma and a bioinformatic analysis of their possible mechanism of action , 2017, FEBS open bio.

[32]  Y. Dang,et al.  Comprehensive analysis of long non-coding RNA PVT1 gene interaction regulatory network in hepatocellular carcinoma using gene microarray and bioinformatics. , 2017, American journal of translational research.

[33]  Zhen-bo Feng,et al.  Clinicopathological significance of STAT4 in hepatocellular carcinoma and its effect on cell growth and apoptosis , 2016, OncoTargets and therapy.

[34]  I. Umelo,et al.  miR-146a Inhibits Cell Growth, Cell Migration and Induces Apoptosis in Non-Small Cell Lung Cancer Cells , 2013, PloS one.

[35]  Hong Yang,et al.  Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma , 2018, BMC Cancer.

[36]  Tongyu Ji,et al.  Long non-coding RNA UCA1 promotes cell progression by acting as a competing endogenous RNA of ATF2 in prostate cancer. , 2017, American journal of translational research.

[37]  M. Matboli,et al.  Association of long noncoding RNA and c-JUN expression in hepatocellular carcinoma , 2016, Expert review of gastroenterology & hepatology.

[38]  Chen Li,et al.  Long noncoding RNA UCA1 induced by SP1 promotes cell proliferation via recruiting EZH2 and activating AKT pathway in gastric cancer , 2017, Cell Death & Disease.

[39]  F. Zhou,et al.  T Cell–Associated Immunotherapy for Hepatocellular Carcinoma , 2017, Cellular Physiology and Biochemistry.

[40]  P. Marcellin,et al.  Liver diseases: A major, neglected global public health problem requiring urgent actions and large‐scale screening , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[41]  C. Park,et al.  HULC and H19 Played Different Roles in Overall and Disease-Free Survival from Hepatocellular Carcinoma after Curative Hepatectomy: A Preliminary Analysis from Gene Expression Omnibus , 2015, Disease markers.

[42]  M. Sallam,et al.  Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma. , 2016, Translational research : the journal of laboratory and clinical medicine.

[43]  Zhen-bo Feng,et al.  Sp1 cooperates with Sp3 to upregulate MALAT1 expression in human hepatocellular carcinoma. , 2015, Oncology reports.

[44]  L. Ming,et al.  Multiple Roles of Autophagy in the Sorafenib Resistance of Hepatocellular Carcinoma , 2017, Cellular Physiology and Biochemistry.

[45]  Shangqi Yang,et al.  LncRNA UCA1 promotes the invasion and EMT of bladder cancer cells by regulating the miR-143/HMGB1 pathway. , 2017, Oncology letters.

[46]  Zhen-bo Feng,et al.  Long non-coding RNA HOTTIP promotes hepatocellular carcinoma tumorigenesis and development: A comprehensive investigation based on bioinformatics, qRT-PCR and meta-analysis of 393 cases , 2017, International journal of oncology.

[47]  Wen-Chao Liu,et al.  Serum long noncoding RNA urothelial carcinoma-associated 1: A novel biomarker for diagnosis and prognosis of hepatocellular carcinoma , 2017, The Journal of international medical research.

[48]  G. Halder,et al.  The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment , 2013, Nature Reviews Drug Discovery.

[49]  S. Diederichs,et al.  Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets. , 2017, Journal of hepatology.

[50]  Yi-huan Luo,et al.  MiR-30a-5p suppresses cell growth and enhances apoptosis of hepatocellular carcinoma cells via targeting AEG-1. , 2015, International journal of clinical and experimental pathology.

[51]  Zhenggang Zhu,et al.  Long noncoding RNA UCA1 promotes tumour metastasis by inducing GRK2 degradation in gastric cancer. , 2017, Cancer letters.